Jill Thompson

HYCOR Biomedical, Inc. manufactures in vitro diagnostic products for allergy and autoimmune testing. The firm’s products include allergy testing, autoimmune testing, HYTEC 288 plus and HCOR ultra-sensitive EIA. It markets the HYTEC, KOVA and AUTOSTAT brands. The company was founded in 1981 and is headquartered in Garden Grove, CA.

Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA.

Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.

RPS Diagnostics, Inc. develops diagnostic solutions and medical instruments. Its product FebriDx is in-office test that uses a finger stick blood sample to help differentiate viral from bacterial acute respiratory infection. The company was founded by Robert P. Sambursky in 2004 and is headquartered in Sarasota, FL.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

Invetech Co. distributes bearings and industrial components. The company is headquartered in Detroit, MI.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN.

Johnson & Johnson Health Care Systems, Inc. provides account management and customer support services. The firm services include contract management, e-business and supply chain. It provides services to health care organizations, hospitals, physician networks and government customers. The company is headquartered in Piscataway, NJ

RWJUH Foundation, Inc. raises funds to support patient care initiatives and capital projects for RWJ Hamilton and the Cancer Institute of New Jersey Hamilton. The company was founded in 1984 and is headquartered in Hamilton, NJ.

Cavitus Solutions Pty Ltd. develops and commercializes liquid phase industrial applications of high power ultrasound technology. It specializes in applications development, engineering design, manufacture and installation of equipment in the area of HPU for new and existing liquid-phase industrial applications with a focus on industries where products such as palm oil, olive oil, dairy and soy proteins are processed. Its customers include agricultural commodities, FMCG, industrial chemicals and pharmaceutical. The company was founded by Darren M. Bates, Ned Strong, Andrew S. Yap and Richard McLoughlin in 2006 and is headquartered in North Sydney, Australia.

Southmore Capital Pty Ltd (Southmore) is a venture capital firm is founded in 2006 by Dr. Jurgen Michaelis. The firm is headquartered in Adelaide.

HeiQ Materials AG develops and manufactures antimicrobial silver and other sustainable textile effects. It offers textile brands innovation research and development, customized chemical manufacturing, and ingredient branding in one. The company was founded by Carlo Centonze and Murray Height in 2005 and is headquartered in Schlieren, Switzerland.

Part of Roche Holding AG, Osmetech Molecular Diagnostics is a healthcare services provider. The company is based in Pasadena, CA.

Beckman Coulter Life Sciences engages in the development, manufacturing, and marketing of products for biomedical testing. It offers air particle counters, cell counters, sizers, and media analyzers, centrifuges, flow cytometers, automated liquid handling solutions, HIAC liquid particle counters, particle size analyzers, and total organic carbon analyzers. The company is headquartered in Indianapolis, IN.

Mothers Choice Products Ltd. distributes prenatal, postnatal and baby products. It offers maternity, Canadian made products, incontinence, natural, ameda breast feeding, breast feeding, newborn and hospital products. The company was founded by Sandra Hass in 1993 and is headquartered in Richmond, Canada.

Planet Innovation Pty Ltd. is a healthtech innovation and Australian commercialization company that specializes in product development and manufacturing. The private company is based in Box Hill, AU. and has subsidiaries in the United States. It was founded in 2009 by Eduardo Vom, Sam Lanyon, Stuart Elliott, and Troy O'Callaghan, with Stuart Elliott serving as the CEO since its inception.

ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL.

Novosanis engages in the development of medical devices. It offers Colli-Pee and VAX-ID. The company was founded on March 12, 2013 by Vanessa Vankerckhoven and Koen Beyers and is headquartered in Wijnegem, Belgium.

Lumos Diagnostics develops and provides diagnostic solutions. It offers assay development, reader development, and point-of-care diagnostic solutions. The company is headquartered in Carlsbad, CA.

Addon Optics Ltd. engages in the development of new technologies in the Ophthalmic industry. The company was founded by Amir Erlichman on October 19, 2015 and is headquartered in Ma'ale Adumim, Israel.

Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation.

Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020.